Thus, our overall findings point toward a role for DPP4 in identifying NAFLD and metabolic diseases in individuals with and without obesity and T2DM, instead of being associated with fat mass and body adiposity itself. This evidence concerns the gene DPP4 and metabolic dysfunction-associated steatotic liver disease.